Christopher C. Woller
Lawyers
Filters
NeoGenomics Follow-On Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the approximately $125 million public offering of common stock of…
Constellation Pharmaceuticals Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with the $60 million initial public offering of common stock of Constellation Pharmaceuticals, Inc. The…
Perspecta Inc. $3.1 Billion Senior Secured Credit Facilities
Davis Polk advised the joint lead arrangers and joint bookrunners, the administrative agent, and the collateral agent, in connection with the $3.1 billion senior secured credit facilities…
Nu Skin Enterprises $750 Million Senior Secured Credit Facilities
Davis Polk advised the joint lead arrangers and joint bookrunners and the administrative agent in connection with a $400 million senior secured term loan and a $350 million senior secured…
Spotify Technology direct listing
Davis Polk advised the financial advisers to Spotify Technology S.A. in connection with Spotify’s direct listing of its ordinary shares on the New York Stock Exchange. The ordinary shares…
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 8,152,986 shares of common stock of…
Editas Medicine, Inc. $50 Million Follow-On Offering
Davis Polk advised the sole book-running manager in connection with the $50 million follow-on offering of 1,970,000 shares of common stock of Editas Medicine, Inc. The common…
Omnicell, Inc. $125 Million SEC-Registered At-The-Market Offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Omnicell, Inc. of its shares of common stock for up to an aggregate amount of $125…